Treatment for Elderly Patients With High Risk Breast Cancer
Status:
Completed
Trial end date:
2004-05-01
Target enrollment:
Participant gender:
Summary
This open-label, multicenter study explored primary and secondary prophylaxis treatment with
a single, fixed-dose, subcutaneous (SC) injection of pegfilgrastim in elderly subjects with
high-risk breast cancer receiving myelosuppressive chemotherapy. The primary objective was to
provide preliminary information on the incidence of protocol defined neutropenic events in
chemotherapy cycle 1.